CONTINUE TO SITE

OR WAIT null SECS

Cataract Surgical Case Study Cataract Therapeutics Glaucoma Insights CME Activities Dry Eye Viewpoint Diabetic Eye Disease Viewpoints Cornea Updates Diabetic Eye Disease Podcast DME Therapy Dry Eye Concepts Dry Eye Flares Eyevance Case Studies Management of Dry Eye Viewpoints Ptosis WetAMD Viewpoints

Clinical

View More Cataract Clinical Diagnosis Cornea Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Refractive Retina Technology Therapeutic Cataract & Refractive Understanding Antibiotic Resistance

Cataract Clinical Diagnosis Cornea Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Refractive Retina Technology Therapeutic Cataract & Refractive Understanding Antibiotic Resistance

All News Blogs COVID-19

Expert Interviews Medical World News Podcasts Viewpoints Insights Case Studies

Health Law & Policy Money Matters Personal Finance Practice Management

Conferences

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Digital Edition Europe Ophthalmology Times Modern Retina Supplements and Featured Publications

Carl Zeiss Meditec submits IDE for MEL-80 laser system

May 4, 2004

Carl Zeiss Meditec announced that the company has submitted an InvestigationalDevice Exemption (IDE) application to the FDA for LASIK utilizing the MEL-80Excimer Laser System.

Related Content:

Pharmacy

Advancement in TED treatment is a bright spot

Comparable conscious sedation methods address individual patient needs

Investigators uncover health care disparities among US patients